Published in J Virol on March 01, 1988
Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J Virol (1992) 1.64
Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein. Proc Natl Acad Sci U S A (1990) 1.37
Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J Virol (1991) 1.21
Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity. J Virol (1990) 0.98
Abelson murine leukemia virus induces platelet-derived growth factor-independent fibroblast growth: correlation with kinase activity and dissociation from full morphologic transformation. Mol Cell Biol (1989) 0.81
Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein. J Virol (2007) 0.80
Generation of recombinant murine retroviral genomes containing the v-src oncogene: isolation of a virus inducing hemangiosarcomas in the brain. J Virol (1991) 0.79
Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV. J Virol (2008) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Calcium-dependent bacteriophage DNA infection. J Mol Biol (1970) 53.43
Stimulation by cyclic adenosine monophosphate of plasmid deoxyribonucleic acid replication and catabolite repression of the plasmid deoxyribonucleic acid-protein relaxation complex. J Bacteriol (1973) 30.43
Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst (1968) 21.44
Protein-tyrosine kinases. Annu Rev Biochem (1985) 14.83
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine. Nature (1980) 6.76
Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli. J Virol (1984) 6.73
Direct transformation of 3T3 cells by Abelson murine leukaemia virus. Nature (1975) 5.97
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell (1980) 5.68
Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci U S A (1983) 4.32
In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.47
Lethal effect of the Abelson murine leukemia virus transforming gene product. Cell (1981) 2.82
Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells. Mol Cell Biol (1983) 2.70
Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell (1983) 2.54
The mouse c-abl locus: molecular cloning and characterization. Cell (1984) 2.33
Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. Virology (1984) 2.22
A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. Proc Natl Acad Sci U S A (1980) 2.16
Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule. J Virol (1980) 2.16
Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertional mutagenesis: positions of viable insertion mutations. Proc Natl Acad Sci U S A (1984) 2.05
Evidence that the Abelson virus protein functions in vivo as a protein kinase that phosphorylates tyrosine. Proc Natl Acad Sci U S A (1981) 1.94
Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity. J Virol (1984) 1.93
Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus. J Virol (1982) 1.90
Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation. J Virol (1980) 1.85
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells. J Virol (1981) 1.73
Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J Biol Chem (1984) 1.71
Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. J Biol Chem (1985) 1.70
The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. J Virol (1985) 1.63
Abelson murine leukemia virus transformation-defective mutants with impaired P120-associated protein kinase activity. J Virol (1980) 1.42
Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality. J Virol (1983) 1.33
A temperature-sensitive mutation constructed by "linker insertion" mutagenesis. Mol Gen Genet (1985) 1.32
Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus. J Virol (1985) 1.29
Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine. Proc Natl Acad Sci U S A (1987) 1.18
Abelson murine leukemia virus: structural requirements for transforming gene function. Proc Natl Acad Sci U S A (1982) 1.09
Chromosomal assignment of the endogenous proto-oncogene C-abl. Science (1982) 1.03
The insulin receptor of rat brain is coupled to tyrosine kinase activity. J Biol Chem (1984) 1.01
A temperature-sensitive mutant of Abelson murine leukemia virus confers inducibility of IgM expression to transformed lymphoid cells. EMBO J (1987) 0.94
The insulin-stimulated receptor kinase is a tyrosine-specific casein kinase. Eur J Biochem (1983) 0.87
The Abelson murine leukemia virus oncogene. Proc Soc Exp Biol Med (1985) 0.84
Molecular and cellular biology of Abelson virus transformation. Curr Top Microbiol Immunol (1983) 0.83
Isolation and analysis of an Abelson murine leukemia virus-encoded tyrosine-specific kinase produced in Escherichia coli. J Biol Chem (1985) 0.83
Characterization of the Abelson murine leukemia virus-encoded tyrosine-specific protein kinase. Methods Enzymol (1983) 0.77
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell (1993) 7.34
Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: a new viral function required for productive infection. Cell (1984) 7.16
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence. Cell (1989) 6.04
A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol (1985) 5.78
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell (1980) 5.68
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (1994) 5.47
Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J Virol (1989) 5.47
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell (1994) 5.00
Sequence and spacing requirements of a retrovirus integration site. J Mol Biol (1988) 4.89
RNA packaging. Curr Top Microbiol Immunol (1996) 4.88
Physical and genetic characterization of deletion mutants of simian virus 40 constructed in vitro. J Virol (1977) 4.23
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J Virol (1993) 4.22
Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell (1985) 3.81
Intramolecular integration within Moloney murine leukemia virus DNA. J Virol (1981) 3.77
Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J (1999) 3.67
Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol (2001) 3.66
Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity (1995) 3.37
Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J Virol (1993) 3.15
Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase. J Virol (1984) 3.14
Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent. J Virol (1983) 3.04
Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc Natl Acad Sci U S A (1988) 3.02
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J Virol (1991) 3.00
Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol (2000) 2.98
Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science (1989) 2.90
Lethal effect of the Abelson murine leukemia virus transforming gene product. Cell (1981) 2.82
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80
Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. J Virol (1988) 2.74
Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev (1992) 2.72
Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J Virol (1989) 2.69
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J Virol (1994) 2.68
The Drosophila snr1 and brm proteins are related to yeast SWI/SNF proteins and are components of a large protein complex. Mol Biol Cell (1995) 2.67
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J Virol (1999) 2.61
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol (1995) 2.56
Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Proc Natl Acad Sci U S A (1997) 2.54
Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J Virol (1995) 2.52
Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene. Mol Cell Biol (1982) 2.51
Specificity and sequence requirements for interactions between various retroviral Gag proteins. J Virol (1994) 2.50
Assays for retroviral reverse transcriptase. Methods Enzymol (1995) 2.43
Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science (1993) 2.40
Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol (1986) 2.33
The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J Virol (1996) 2.31
Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J Virol (1984) 2.30
Role for the target enzyme in deactivation of photoreceptor G protein in vivo. Science (1998) 2.29
The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J Virol (1989) 2.27
Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells. Cell (1976) 2.25
Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol (1996) 2.23
Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure (1995) 2.20
Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell (1991) 2.19
A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J Virol (1992) 2.18
Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J Virol (1986) 2.18
Retinal degeneration in mice lacking the gamma subunit of the rod cGMP phosphodiesterase. Science (1996) 2.11
Expression of enzymatically active reverse transcriptase in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.11
Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain. Proc Natl Acad Sci U S A (1989) 2.06
Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertional mutagenesis: positions of viable insertion mutations. Proc Natl Acad Sci U S A (1984) 2.05
Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev (1995) 2.04
Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J Biol Chem (1985) 2.02
5' regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal. Virology (1995) 1.95
Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus. J Virol (1982) 1.90
Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences. J Virol (1985) 1.90
Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology (1994) 1.88
Point mutations in the P30 domain of the gag gene of Moloney murine leukemia virus. Virology (1985) 1.85
Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli. J Virol (1986) 1.84
Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science (1985) 1.82
Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene. Science (1985) 1.77
Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J Virol (1995) 1.77
Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting. J Virol (1990) 1.75
Genetic assay for multimerization of retroviral gag polyproteins. J Virol (1992) 1.74
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells. J Virol (1981) 1.73
Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1991) 1.73
Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance. Virology (1991) 1.73
Structure of a cloned circular retroviral DNA containing a tRNA sequence between the terminal repeats. J Virol (1986) 1.72
Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem (1999) 1.68
Gene product of Moloney murine leukemia virus required for proviral integration is a DNA-binding protein. J Mol Biol (1988) 1.67
Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function. J Virol (1991) 1.66
Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.65
Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J Virol (1996) 1.64
Mutants of murine leukemia viruses and retroviral replication. Biochim Biophys Acta (1987) 1.57
Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities. J Biol Chem (1993) 1.54
Infection of nondividing cells by Rous sarcoma virus. J Virol (2001) 1.53
Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet (2000) 1.51
Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection. Virology (1996) 1.47
Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection. Mol Biol Cell (1999) 1.47
Cellular motor protein KIF-4 associates with retroviral Gag. J Virol (1999) 1.43
High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Mol Cell Biol (1990) 1.43
Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H. J Virol (1992) 1.41
RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc Natl Acad Sci U S A (1993) 1.41
Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene (1997) 1.38
Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. J Virol (1993) 1.37
Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein. Proc Natl Acad Sci U S A (1990) 1.37
Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Proc Natl Acad Sci U S A (2001) 1.36
Structure and formation of circular dimers of simian virus 40 DNA. J Virol (1977) 1.35
Two defective forms of reverse transcriptase can complement to restore retroviral infectivity. EMBO J (1993) 1.33
Replication defect of moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides. J Virol (1998) 1.33
A temperature-sensitive mutation constructed by "linker insertion" mutagenesis. Mol Gen Genet (1985) 1.32
Construction, propagation and expression of simian virus 40 recombinant genomes containing the Escherichia coli gene for thymidine kinase and a Saccharomyces cerevisae gene for tyrosine transfer RNA. J Mol Biol (1979) 1.31
Cloning and analysis of reverse transcript P160 genomes of Abelson murine leukemia virus. J Virol (1983) 1.30
Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol Cell Biol (1999) 1.28
Mutagenesis of the Glu-89 residue in human immunodeficiency virus type 1 (HIV-1) and HIV-2 reverse transcriptases: effects on nucleoside analog resistance. J Virol (1992) 1.26